STAT+: PBMs agree to display TrumpRx drug prices

The FDA granted accelerated approval to Bristol Myers Squibb's Zenbexus, an oral treatment for advanced multiple myeloma, marking the debut of a new class of medicine for the blood cancer and the first drug cleared by U.S. regulators using a more sensitive measure of remission.

The newsletter also reports that pharmacy benefit managers have agreed to display TrumpRx drug prices, and that Novartis won a key U.K. patent fight over its heart failure drug Entresto.